Tagged with CEO

Pharma Actelion’s global CEO and co-founder, Dr Jean-Paul Clozel, discusses diversifying the company’s portfolio, prioritizing internal research over inorganic acquisitions, and retaining a spirit of independence and innovation during a period of rapid growth.   2015 was a fantastic year for the company, the best yet, passing the USD two billion…

Pharma Country Manager Giovanna Labbate talks how Gedeon Richter aims to become the point of reference for women’s health in Italy, the successful launch of ESMYA, and the establishment of the affiliate five years ago. The Gedeon Richter Italy affiliate was established in 2011. What was the rationale behind starting this…

Pharma Dominique Costantini, the CEO of OSE Pharma, a French biotech company developing immunotherapy products against late-stage (invasive and metastatic) cancer discusses the company’s unique targeted approach based on a patented neo-epitopes combination, its plans to break into the immuno-oncology domain and its perspectives on the French regulatory and biotech environments, and emphasizes…

pharma Mr Martinez, President of Santen France, reveals how Santen’s decision to acquire the French pharmaceutical company Novagali in 2011, was based on its desire to project itself as an innovative ophthalmic player across the whole of Europe and why 2015 was a significant year for the group, receiving European marketing approval…

Pharma Nanomedicine is expected to become the third pillar of drug development following pharmaceuticals and biologics. The CEO of Dutch contract research and manufacturing organization ChemConnection explains how the company helps customers bring nanomedicine drug delivery systems and APIs from discovery to clinic, fast. Could you please introduce ChemConnection to our…

pharma Escalate Sciences is a Puerto Rican specialized science-based consulting firm focused on R&D, tech transfer, process design & improvement, analytical development and characterization. The company also serves different aspects of the life-sciences industry including project management, validation, qualification, statistical analysis, facility start-up, regulatory & compliance, reformulation and testing services. Its…

pharma Francisco García was appointed as the executive director for the Puerto Rico Manufacturers Association (PRMA) in August 2015. He stresses the importance of developing Puerto Rico’s entrepreneurial talent and startup clusters as his main initiatives. As you have recently taken over as executive director of PRMA, could you outline the…

pharma The General Manager of Boehringer Ingelheim South Africa talks about changes that are required to the healthcare system, with far more government/private partnerships, helping to unlock the country´s potential, why South Africa acts as a springboard for many companies looking to develop their footprint in the region, making it the…

QuantiLAB After recently signing a service level agreement with Mérieux NutriSciences in May 2015, Bertrand Baudot, Managing Director of QuantiLAB explains the company’s plans for the future. He also discusses the challenges and, more importantly, highlights the various opportunities in the Healthcare and Life Sciences sector on Mauritius. In its first…

pharma Luis Alemañy came to American Tools, Inc. as general manager in 2014 following a career largely focused on multinationals. He talks about the company’s new direction and their large international client base that has come about as a result of over 40 years of high-quality sheet metal manufacturing primarily for…

pharma Pierre Banzet, President of Group Synerlab, one of the top ten French CMOs, discusses his group’s ambitious European expansion strategy, driven by their specialties in multi-dose, preservative-free eye drops, generics, medical devices and hospital markets, and uniqueness in terms of its culture of customer service. He also discusses his perspective…

pharma The CEO and founder of ModiQuest discusses how, with its unique, fully-integrated antibody generation and development platform, the company is developing antibodies for potentially groundbreaking therapies for the prevention and treatment of rheumatoid arthritis and growing its already well-established CRO arm serving clients from around the world. Could you introduce…